Menu

Blog

Apr 20, 2024

Researchers set new standards for nanoparticles, helping patients with MS, ALS, Parkinson’s disease

Posted by in categories: biotech/medical, nanotechnology, neuroscience

Is it possible for nanoparticles to go through the digestive system and deliver medicine directly to the brain tissue? Researchers from Michigan State University say yes, and their latest findings are expected to benefit patients with neurodegenerative disorders like multiple sclerosis, or MS; amyotrophic lateral sclerosis, or ALS; and Parkinson’s disease, or PD.

Comments are closed.